Aurora Oncology operates within the biotechnology and health care industries, contributing to the advancement of medical science. The focus on targeted therapeutics indicates a promising approach to tackling the challenges posed by non-muscle invasive bladder cancer. The recent grant investment signals recognition and support for the potential impact of Aurora Oncology's work.
Aurora Oncology
Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precision.
Founded 2011
Grant
Total: $250.00K
Biotechnology, Health Care
General Information
Company Name
Aurora Oncology
Founded Year
2011
Industries
Biotechnology, Health Care
Funding Stage
Grant
Social
BounceWatch is an independent company data service, not affiliated with Aurora Oncology. To contact Aurora Oncology, visit auroraoncology.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Aurora Oncology compare?
A PDF of Aurora Oncology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Aurora Oncology soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Aurora Oncology on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Aurora Oncology
Business keywords: biopharmaceutical company, clinical-stage, targeted therapeutics, bladder cancer, non-muscle invasive, precision medicine, oncology, cancer treatment, medical imaging, precision oncology
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $250.00K | 1 |
Advanced Industries Accelerator (AIA) Program
|
18 Nov 2021 |
Aurora Oncology Alternatives & Competitors
View All Alternatives
Aurora Oncology vs
CG Oncology
United States
Attacking Bladder Cancer for a Better Tomorrow
Series F
121 employees
Biotechnology, Health Care
Aurora Oncology vs
Anchiano Therapeutics
United States
Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat...
Post-IPO Equity
1 employees
Biotechnology, Health Care
Aurora Oncology vs
Apexigen
United States
Creating Transformative Immunotherapies for Patients with Cancer
Post-IPO Equity
11 employees
Biopharma, Biotechnology
FAQ About Aurora Oncology
Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precision.
Aurora Oncology was founded in 2011.
Aurora Oncology operates in Biotechnology and Health Care. Its work centres on biopharmaceutical company, clinical-stage, targeted therapeutics and bladder cancer.
Aurora Oncology has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Grant.
Top alternatives and competitors to Aurora Oncology include CG Oncology, Anchiano Therapeutics, Apexigen, Soricimed Biopharma Inc., SOLID Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aurora Oncology and CG Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Aurora Oncology, https://bouncewatch.com/company/aurora-oncology, updated 4 August 2024. When citing, please name BounceWatch and link this page.
